Study looks at effectiveness of pharmacist-delivered MAT to treat opioid use disorder

OPIOID STUDY: Susan Lim, site manager, and Joe Robillard, pharmacy technician, work on prescription orders at a Genoa Healthcare pharmacy inside a Gateway Healthcare clinic in Pawtucket. Genoa is collaborating with Rhode Island Hospital and CODAC Behavioral Healthcare on a study examining the effectiveness of pharmacist-delivered, medication-assisted treatment for opioid-use disorder.
 / PBN PHOTO/
RUPERT WHITELEY
OPIOID STUDY: Susan Lim, site manager, and Joe Robillard, pharmacy technician, work on prescription orders at a Genoa Healthcare pharmacy inside a Gateway Healthcare clinic in Pawtucket. Genoa is collaborating with Rhode Island Hospital and CODAC Behavioral Healthcare on a study examining the effectiveness of pharmacist-delivered, medication-assisted treatment for opioid-use disorder.
 / PBN PHOTO/
RUPERT WHITELEY
Efforts to curb the opioid epidemic include increasing access to care and reducing stigma, goals officials say a $1.6 million National Institutes of Health-funded, three-year study of pharmacy-administered, medication-assisted opioid addiction treatment promises to achieve. The study is a collaborative effort between Rhode Island Hospital, CODAC Behavioral Healthcare and Genoa Healthcare, seeking the effectiveness of…

Subscriber-only Content

This article is available only to PBN Subscribers. To get unlimited access, please subscribe by following the link below.

Subscribe Now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -